Hamilton E, Cortes J, Ozyilkan O, Chen SC, et al. nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2- metastatic breast cancer. Breast Cancer Res Treat 2022 Jul 12. pii: 10.1007/s10549-022-06662.
PMID: 35829935